$Immutep(IMMP.US)$Data From Safety Lead-in Phase of AIPAC-003 Confirmed Complete Response In A Patient With Metastatic Breast Cancer Refractory To Several Lines Of Therapy Achieved During Combination Treatment With 90mg Efti And Paclitaxel Benzinga· 3 mins ago Immutep Limited ((ASX: IMM, NASDAQ:IMMP) ("Immutep" or "the Company"), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces encouraging efficacy, safety,...
$Immutep(IMMP.US)$Initial Clinical Data Reported From Immutep's Efti Combined With Radiotherapy And Checkpoint Inhibitor From Phase II Trial In Soft Tissue Sarcoma Benzinga· 2 mins ago Novel triple combination of efti with radiotherapy and anti-PD-1 therapy is well tolerated and has led to encouraging initial efficacy data in EFTISARC-NEO Phase II trial Four of six patients treated have very good, near-complete pathologic responses (primary endpoint of study) that are rarely observed with...
$Immutep(IMMP.US)$Immutep Announced Tuesday, Data From Efti In Combination With Keytruda In First Line Head And Neck Squamous Cell Carcinoma Patients Who Do Not Express PD-L1 Shows A Preliminary 26.9% Response Rate, The Primary Endpoint Of The Study Benzinga· 7 mins ago
$Immutep(IMMP.US)$Immutep Announced Tuesday, Positive Feedback From Spanish Medicines Agency For Upcoming TACTI-004 Registrational Trial In Metastatic Non-Small Cell Lung Cancer
Immutep股票討論區
Benzinga· 3 mins ago
Immutep Limited ((ASX: IMM, NASDAQ:IMMP) ("Immutep" or "the Company"), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces encouraging efficacy, safety,...
Benzinga· 2 mins ago
Novel triple combination of efti with radiotherapy and anti-PD-1 therapy is well tolerated and has led to encouraging initial efficacy data in EFTISARC-NEO Phase II trial
Four of six patients treated have very good, near-complete pathologic responses (primary endpoint of study) that are rarely observed with...
Benzinga· 7 mins ago
IMMP EEIQ NVTS ENVB ZURA MBOT
$Immutep(IMMP.US)$ $EpicQuest Education(EEIQ.US)$ $納微半導體(NVTS.US)$ $Enveric Biosciences(ENVB.US)$ $Zura Bio(ZURA.US)$ $Microbot Medical(MBOT.US)$
暫無評論